Article ID Journal Published Year Pages File Type
8744732 Clinical Microbiology and Infection 2018 6 Pages PDF
Abstract
Amoxicillin may reduce the risk of illness deterioration in patients with a combined bacterial and viral infection. We found no clinically meaningful benefit from amoxicillin treatment in other subgroups.
Keywords
Related Topics
Life Sciences Immunology and Microbiology Microbiology
Preview
Amoxicillin for acute lower respiratory tract infection in primary care: subgroup analysis by bacterial and viral aetiology
Authors
, , , , , , , , ,